QNRX

Quoin Pharmaceuticals, Ltd.

0.77 USD
+0.01 (+1.79%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Quoin Pharmaceuticals, Ltd. stock is up 16.03% since 30 days ago. The next earnings date is Jul 31, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 50% of the previous 7 May’s closed higher than April.

About Quoin Pharmaceuticals, Ltd.

Quoin Pharmaceuticals, Ltd. focuses on the development of therapeutic products for rare and orphan diseases. It offers QRX003, a topical lotion to treat Netherton Syndrome; QRX004 for the treatment dystrophic epidermolysis bullosa; and QRX006, a therapy to treat rare skin disease.